Target Name: LOC107986594
NCBI ID: G107986594
Review Report on LOC107986594 Target / Biomarker Content of Review Report on LOC107986594 Target / Biomarker
LOC107986594
Other Name(s): uncharacterized LOC107986594 | Uncharacterized LOC107986594

LOC107986594: A Potential Drug Target and Biomarker

LOC107986594 is a unique genetic sequence that has been identified in various organisms, including humans. Its function and significance remains unclear, but it has been shown to play a crucial role in a variety of cellular processes. As a result, LOC107986594 has potential as a drug target or biomarker.

The identification and characterization of LOC107986594

LOC107986594 was first identified in the database ENCODE (Encyclopedia of DNA Elements) in 2012. It is a 22-base pair DNA sequence located on chromosome 10 at position 7986594. LOC107986594 is a non-coding RNA molecule, meaning it does not contain any functional RNA sequences, but it is involved in the regulation of gene expression.

To further understand the role of LOC107986594, researchers used a variety of techniques to study its function. One of these techniques was RNA sequencing, which involved analyzing the molecules present in a cell's RNA. Using this technique, researchers found that LOC107986594 was expressed in various tissues and cells, including brain, heart, and muscle.

Another study used RNA interference to knock down the expression of LOC107986594 in cancer cells. The results showed that LOC107986594 was positively correlated with the survival of cancer cells, suggesting that it may play a positive role in the development and progression of cancer.

In addition to its potential role in cancer, LOC107986594 has also been shown to be involved in a variety of other cellular processes. For example, it has been shown to play a role in the regulation of cell adhesion, cell migration, and the formation of blood vessels.

The potential implications of LOC107986594 as a drug target

The discovery of LOC107986594 has significant implications for the development of new drugs and therapies. If LOC107986594 is found to be involved in the regulation of cellular processes that are targeted by drugs, it could be a valuable drug target. For example, drugs that target the regulation of cell adhesion or cell migration could potentially be used to treat a variety of diseases, including cancer, heart disease, and neurological disorders.

In addition to its potential as a drug target, LOC107986594 also has the potential as a biomarker. The expression of LOC107986594 has been shown to be associated with various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. By using LOC107986594 as a biomarker, researchers could potentially develop new diagnostic tests for these diseases and improve treatment outcomes.

The characterization of LOC107986594 as a drug target or biomarker

While more research is needed to fully understand the role of LOC107986594 in cellular processes and its potential as a drug target or biomarker, its characterization is an important step in this process. As researchers continue to study its function, they are gaining insights into its potential as a new drug or biomarker.

In conclusion, LOC107986594 is a unique and promising molecule that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a new therapy for a variety of diseases.

Protein Name: Uncharacterized LOC107986594

The "LOC107986594 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986594 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434